These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 28571522)

  • 1. Risk factors predicting the survival of pediatric patients with relapsed/refractory non-Hodgkin lymphoma who underwent hematopoietic stem cell transplantation: a retrospective study from the Turkish pediatric bone marrow transplantation registry.
    Hazar V; Kesik V; Karasu GT; Öztürk G; Küpesiz A; Kılıç SÇ; Ataş E; Uygun V; Eker N; Erbey F; Bengoa ŞY; Emir S; Anak S; Öniz H; Daloğlu H; Aksoylar S; Koçak Ü; Karakükçü M; Elli M; Kurucu N; Yeşilipek A
    Leuk Lymphoma; 2018 Jan; 59(1):85-96. PubMed ID: 28571522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of pediatric patients with lymphoma following stem cell transplant: a single institution report.
    Sumaili H; Al-Kofide A; Al-Seraihi A; Ayas M; Siddiqui K; El-Solh H; Al-Jefri A; Al-Ahmari A; Mohamed A; Anas M; Belgaumi AF
    Leuk Lymphoma; 2015 May; 56(5):1327-34. PubMed ID: 25139691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive chemotherapy with hematopoietic stem-cell support for children with recurrent or refractory NHL.
    Sandlund JT; Bowman L; Heslop HE; Krance R; Mahmoud H; Pui C-; Hale G; Benaim E
    Cytotherapy; 2002; 4(3):253-8. PubMed ID: 12194721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic hematopoietic stem cell transplant for relapsed and refractory non-Hodgkin lymphoma in pediatric patients.
    Naik S; Martinez CA; Omer B; Sasa G; Yassine K; Allen CE; Kamdar K; Orth R; Wu M; Leung K; Gottschalk S; Brenner MK; Heslop HE; Krance RA
    Blood Adv; 2019 Sep; 3(18):2689-2695. PubMed ID: 31511228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-year follow-up of pediatric patients with non-Hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation.
    Giulino-Roth L; Ricafort R; Kernan NA; Small TN; Trippett TM; Steinherz PG; Prockop SE; Scaradavou A; Chiu M; O'Reilly RJ; Boulad F
    Pediatr Blood Cancer; 2013 Dec; 60(12):2018-24. PubMed ID: 24038967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents.
    Gross TG; Hale GA; He W; Camitta BM; Sanders JE; Cairo MS; Hayashi RJ; Termuhlen AM; Zhang MJ; Davies SM; Eapen M
    Biol Blood Marrow Transplant; 2010 Feb; 16(2):223-30. PubMed ID: 19800015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-Hodgkin lymphoma: a salvage regimen with high response rates before autologous stem cell transplantation.
    Oyan B; Koc Y; Ozdemir E; Kars A; Turker A; Tekuzman G; Kansu E
    Biol Blood Marrow Transplant; 2005 Sep; 11(9):688-97. PubMed ID: 16125639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic stem cell transplantation in children and adolescents with relapsed or refractory B-cell non-Hodgkin lymphoma.
    Fujita N; Kobayashi R; Atsuta Y; Iwasaki F; Suzumiya J; Sasahara Y; Inoue M; Koh K; Hori T; Goto H; Ichinohe T; Hashii Y; Kato K; Suzuki R; Mitsui T
    Int J Hematol; 2019 Apr; 109(4):483-490. PubMed ID: 30701466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic stem cell transplantation using lymphoablative rather than myeloablative conditioning regimen for relapsed or refractory lymphomas.
    Yoon JH; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Min WS; Cho SG
    Hematol Oncol; 2017 Mar; 35(1):17-24. PubMed ID: 25782369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission.
    Vose JM; Rizzo DJ; Tao-Wu J; Armitage JO; Bashey A; Burns LJ; Christiansen NP; Freytes CO; Gale RP; Gibson J; Giralt SA; Herzig RH; Lemaistre CF; McCarthy PL; Nimer SD; Petersen FB; Schenkein DP; Wiernik PH; Wiley JM; Loberiza FR; Lazarus HM; van Biesen K; Horowitz MM
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):116-27. PubMed ID: 14750077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experience.
    Ciochetto C; Botto B; Passera R; Bellò M; Benevolo G; Boccomini C; Castellino A; Chiappella A; Freilone R; Nicolosi M; Orsucci L; Pecoraro C; Pregno P; Bisi G; Vitolo U
    Ann Hematol; 2018 Sep; 97(9):1619-1626. PubMed ID: 29663029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous peripheral blood stem cell transplantation in children with non-Hodgkin's lymphoma: A report from the Korean society of pediatric hematology-oncology.
    Won SC; Han JW; Kwon SY; Shin HY; Ahn HS; Hwang TJ; Yang WI; Lyu CJ
    Ann Hematol; 2006 Nov; 85(11):787-94. PubMed ID: 16932891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome analysis of high-dose chemotherapy and autologous stem cell transplantation in adolescent and young adults with relapsed or refractory Hodgkin lymphoma.
    Akhtar S; Rauf SM; Elhassan TA; Maghfoor I
    Ann Hematol; 2016 Sep; 95(9):1521-35. PubMed ID: 27376363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of autologous hematopoietic stem cell transplantation in children and adolescents with relapsed or refractory Hodgkin's lymphoma.
    Hazar V; Kesik V; Aksoylar S; Karakukcu M; Ozturk G; Kupesiz A; Atas E; Oniz H; Kansoy S; Unal E; Tanyeli A; Erbey F; Elli M; Tacyildiz N; Karasu GT; Kocak U; Anak S; Yilmaz Bengoa S; Sezgin G; Atay D; Unal E; Uygun V; Kurucu N; Kaya Z; Yesilipek A;
    Pediatr Transplant; 2015 Nov; 19(7):745-52. PubMed ID: 26346042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphoma.
    Doocey RT; Toze CL; Connors JM; Nevill TJ; Gascoyne RD; Barnett MJ; Forrest DL; Hogge DE; Lavoie JC; Nantel SH; Shepherd JD; Sutherland HJ; Voss NJ; Smith CA; Song KW
    Br J Haematol; 2005 Oct; 131(2):223-30. PubMed ID: 16197454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin's lymphoma.
    Stockerl-Goldstein KE; Horning SJ; Negrin RS; Chao NJ; Hu WW; Long GD; Hoppe RT; Amylon MD; Brown BW; Wong RM; Blume KG
    Biol Blood Marrow Transplant; 1996 May; 2(2):76-85. PubMed ID: 9118302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autologous stem-cell transplantations in children with non-Hodgkin lymphomas].
    Wójcik B; Kowalczyk JR; Chybicka A; Wachowiak J; Drabko K; Zaucha-Prazmo A; Choma M; Gorczyńska E; Toporski J; Turkiewicz D; Kałwak K; Pieczonka A; Boruczkowski D
    Przegl Lek; 2004; 61 Suppl 2():53-6. PubMed ID: 15686047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Factors and a New Prognostic Index Model for Children and Adolescents with Hodgkin's Lymphoma Who Underwent Autologous Hematopoietic Stem Cell Transplantation: A Multicenter Study of the Turkish Pediatric Bone Marrow Transplantation Study Group.
    Kesik V; Ataş E; Karakükcü M; Aksoylar S; Erbey F; Taçyıldız N; Küpesiz A; Öniz H; Ünal E; Kansoy S; Öztürk G; Elli M; Kaya Z; Ünal E; Hazar V; Yılmaz Bengoa Ş; Karasu G; Atay D; Dağdemir A; Ören H; Koçak Ü; Yeşilipek MA
    Turk J Haematol; 2016 Dec; 33(4):265-272. PubMed ID: 27094103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic stem cell transplantation does not increase the risk of infection-related complications for pediatric patients with Hodgkin and non-Hodgkin lymphomas: A multicenter nationwide study.
    Zając-Spychała O; Wachowiak J; Czyżewski K; Dziedzic M; Wysocki M; Zalas-Więcek P; Szmydki-Baran A; Hutnik Ł; Matysiak M; Małas Z; Badowska W; Gryniewicz-Kwiatkowska O; Gietka A; Dembowska-Bagińska B; Semczuk K; Dzierżanowska-Fangrat K; Bartnik M; Ociepa T; Urasiński T; Frączkiewicz J; Salamonowicz M; Kałwak K; Gorczyńska E; Chybicka A; Irga-Jaworska N; Bień E; Drożyńska E; Chełmecka-Wiktorczyk L; Balwierz W; Zak I; Pierlejewski F; Młynarski W; Urbanek-Dądela A; Karolczyk G; Stolpa W; Sobol-Milejska G; Płonowski M; Krawczuk-Rybak M; Musiał J; Chaber R; Gamrot-Pyka Z; Woszczyk M; Tomaszewska R; Szczepański T; Kowalczyk J; Styczyński J
    Transpl Infect Dis; 2020 Aug; 22(4):e13292. PubMed ID: 32285579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic stem cell transplantation for non-Hodgkin lymphoma.
    Bhatt VR; Vose JM
    Hematol Oncol Clin North Am; 2014 Dec; 28(6):1073-95. PubMed ID: 25459180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.